Shares of Solventum Corp. advanced 5.40% to $70.23 Friday, on what proved to be an all-around dismal trading session for the ...

Solventum, spun off from 3M in April 2024, reported $2.1 billion in sales for the first quarter of 2025, an increase of 2.6%.

Solventum Corporation's stock dropped 20% despite strong earnings & its recent $11.5B Purification sale. Click here to find ...

Solventum SOLV reported first-quarter 2025 adjusted earnings per share (EPS) of $1.34, which beat the Zacks Consensus ...

SOLV's Q1 performance is likely to have been hurt by below-par revenue growth in several markets, coupled with currency ...

Solventum Corp., the Minnesota health care products manufacturer that spun out of 3M, reported better-than-expected results ...

I would like to welcome everyone to the Solventum first-quarter 2025 earnings call. As a reminder, this call is being recorded. (Operator Instructions) Thank you. I would now like to turn the program ...

Solventum Corp. closed 22.15% below its 52-week high of $85.92, which the company reached on February 26th.

The health care company posted revenue of $2.07 billion in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $2 billion. Solventum expects full-year earnings in ...

Reported sales increased 2.6%; organic sales increased 4.3% Increases full year organic sales growth outlook by 50 bps to +1.5% to +2.5% ST. PAUL, Minn., May ...

Shares of Solventum Corp. SOLV advanced 1.74% to $66.63 Thursday, on what proved to be an all-around positive trading session ...

Solventum SOLV is scheduled to release first-quarter 2025 results on May 8, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 7.63%.